Cite
HARVARD Citation
Puca, E. et al. (2020). The antibody‐based delivery of interleukin‐12 to solid tumors boosts NK and CD8+ T cell activity and synergizes with immune checkpoint inhibitors. International journal of cancer. 146 (9), pp. 2518-2530. [Online].